Skip to content

Homeopathy drug proving study to observe clinical symptoms of H-009 in healthy volunteers.

Homeopathic Drug Proving study to evaluate the clinical Symptoms of H-009 in healthy volunteers. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/03/002506
Enrollment
22
Registered
2012-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: H-009: H-009 30c pills Dose: 6 pills daily for 5 weeks. Control Intervention1: Placebo: Placebo 30c pills Dose: 6 pills daily for 5 weeks. Control Intervention2: Not applicable: Not App

Sponsors

Homeopathy India Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteer. The person must be trustworthy, able and ready to express and describe his experiences during the Proving. The usual habits and conduct of life should be continued. The person should not plan to begin medical or surgical treatments like dentist, surgery or psychotherapy during the drug proving. The person selected for proving must be in such a mental and legalstate so as to able to exercise fully his/her choice and written consent should be obtained. Whose ECG and X ray reports are within normal range limits.

Exclusion criteria

Exclusion criteria: Current medical treatments or Homeopathic drugs in the preliminary observation period or during the Proving. Consumption of prescribed drugs (including Homeopathic) in the past four weeks. Contraceptive pills in the past three months. Surgical treatment within past two months. Pregnancy, breast feeding Persons suffering from allergic manifestations particularly pertaining to respiratory system and skin should not be included in proving. volunteers with history of diabetes, hypertension and hypothyroid should not be included in proving Volunteers who are drug addicts should not be included in proving

Design outcomes

Primary

MeasureTime frame
Symptoms experienced by provers will be recorded.Timepoint: Symptoms experienced by provers will be recorded daily and will be analyzed at the end of 6 week period.

Secondary

MeasureTime frame
Safety parameters - including blood investigations ECG and X ray.Timepoint: Pre( screening) and post ( after completion of 5 doses of proving substance)

Countries

India

Contacts

Public ContactDr Rajesh Shah

Life Force

rajesh@lifeforce.in02266888888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026